Ads

 

Ads

 

Ads

 

World Top 100 Pharmaceutical Companies List by Market Cap as of August 2026

World Top 100 Pharmaceutical Companies List by Market Cap as of August 2026, World Biggest 100 Pharmaceutical Companies by Market Cap, World Largest 100 Pharmaceutical Companies in the World by market cap as of August 2026.

Metatag Title
World Top Pharmaceutical Companies in 2026
Metatag Abstract
World Top Pharmaceutical Companies by Market Cap in 2026, World Largest Pharmaceutical Companies by Market Cap in 2026.
  1. Pfizer India

    World Rank (Aug-2026)
    5,818
    Market Cap (Aug-2026)
    2.329 Billion USD
    World Rank (Jan-05-2024)
    5,051
    Market Cap (Jan-05-2024)
    2.421 Billion USD
    World Rank (Jul-30-2023)
    5,381
    Market Cap (Jul-30-2023)
    2.211 Billion USD
    World Rank (Dec-25-2022)
    4,818
    Market Cap (Dec-25-2022)
    2.389 Billion USD
    World Rank (Jan-07-2022)
    4,797
    Market Cap (Jan-07-2022)
    3.04 Billion USD
    Annual Revenue in USD
    327 Million USD
    Annual Net Income in USD
    77 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile
    Pharmaceuticals company with headquarters is in India.
  2. Dermapharm Holding SE

    World Rank (Aug-2026)
    5,827
    Market Cap (Aug-2026)
    2.325 Billion USD
    World Rank (Jan-05-2024)
    4,956
    Market Cap (Jan-05-2024)
    2.498 Billion USD
    World Rank (Jul-30-2023)
    4,812
    Market Cap (Jul-30-2023)
    2.594 Billion USD
    World Rank (Dec-25-2022)
    5,241
    Market Cap (Dec-25-2022)
    2.127 Billion USD
    World Rank (Jan-07-2022)
    3,390
    Market Cap (Jan-07-2022)
    4.80 Billion USD
    Annual Revenue in USD
    1,129 Million USD
    Annual Operating Income in USD
    267 Million USD
    Annual Net Income in USD
    148 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Dermapharm Holding SE is a Pharmaceutical company. It has around 950 marketing authorizations for more than 250 active pharmaceutical ingredients. The company annual revenue is 700.9 million EUR as on 2019. The headquarters is in Germany.

  3. Tonghua Golden-Horse Pharmaceutical Industry Coltd

    World Rank (Aug-2026)
    5,904
    Market Cap (Aug-2026)
    2.279 Billion USD
    World Rank (Jan-05-2024)
    4,778
    Market Cap (Jan-05-2024)
    2.646 Billion USD
    World Rank (Jul-30-2023)
    10,283
    Market Cap (Jul-30-2023)
    0.750 Billion USD
    World Rank (Dec-25-2022)
    9,634
    Market Cap (Dec-25-2022)
    0.793 Billion USD
    World Rank (Jan-07-2022)
    11,465
    Market Cap (Jan-07-2022)
    0.70 Billion USD
    Headquarters Country
  4. United Laboratories International Holdings

    World Rank (Aug-2026)
    5,923
    Market Cap (Aug-2026)
    2.267 Billion USD
    World Rank (Jan-05-2024)
    6,317
    Market Cap (Jan-05-2024)
    1.675 Billion USD
    World Rank (Jul-30-2023)
    6,945
    Market Cap (Jul-30-2023)
    1.479 Billion USD
    World Rank (Dec-25-2022)
    7,963
    Market Cap (Dec-25-2022)
    1.090 Billion USD
    World Rank (Jan-07-2022)
    9,143
    Market Cap (Jan-07-2022)
    1.05 Billion USD
    Annual Revenue in USD
    1,412 Million USD
    Annual Net Income in USD
    144 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    United Laboratories International Holdings is the leading comprehensive pharmaceutical company engaged in the R&D(Research and development), manufacturing and selling of finished products, bulk medicines and intermediate products. The company annual revenue is 9,703 million HKD and annual net income is 988 million HKD for year ending December 2021. The headquarters is in Hong Kong.
  5. Veloxis Pharmaceuticals A/S

    World Rank (Aug-2026)
    5,944
    World Rank (Jan-05-2024)
    5,944
    World Rank (Jul-30-2023)
    5,944
    World Rank (Dec-25-2022)
    5,944
    World Rank (Jan-07-2022)
    5,944
    Headquarters Country
  6. Harmony Biosciences Holdings Inc.

    World Rank (Aug-2026)
    5,989
    Market Cap (Aug-2026)
    2.220 Billion USD
    World Rank (Jan-05-2024)
    5,928
    Market Cap (Jan-05-2024)
    1.871 Billion USD
    World Rank (Jul-30-2023)
    5,534
    Market Cap (Jul-30-2023)
    2.111 Billion USD
    World Rank (Dec-25-2022)
    3,759
    Market Cap (Dec-25-2022)
    3.363 Billion USD
    World Rank (Jan-07-2022)
    5,877
    Market Cap (Jan-07-2022)
    2.22 Billion USD
    Annual Revenue in USD
    868 Million USD
    Annual Operating Income in USD
    208 Million USD
    Annual Net Income in USD
    159 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Harmony Biosciences Holdings is a Pharmaceutical company. It focuses on disorders of sleep and wakefulness and currently working to advance the understanding of narcolepsy and provide information and resources to people who live with and healthcare professionals who treat, this chronic, debilitating neurologic disorder. The headquarters is in USA.

    Facts About Company

    The company annual revenue was 437 million USD and net income was 181 million USD as on 2022.

  7. Biohaven Pharmaceutical Holding Company

    World Rank (Aug-2026)
    6,000
    Market Cap (Aug-2026)
    2.211 Billion USD
    World Rank (Jan-05-2024)
    3,972
    Market Cap (Jan-05-2024)
    3.399 Billion USD
    World Rank (Jul-30-2023)
    7,470
    Market Cap (Jul-30-2023)
    1.300 Billion USD
    World Rank (Dec-25-2022)
    8,706
    Market Cap (Dec-25-2022)
    0.934 Billion USD
    World Rank (Jan-07-2022)
    2,147
    Market Cap (Jan-07-2022)
    8.44 Billion USD
    Annual Revenue in USD
    463 Million USD
    Annual Operating Income in USD
    -704 Million USD
    Annual Net Income in USD
    -847 Million USD
    Annual Results for Period Ending
    For year ending December-2021
    Headquarters Country
    Company Profile

    Biohaven Pharmaceutical Holding Company is a Clinical Stage Biopharmaceutical company. It portfolio is comprised of innovative, late stage product candidates targeting neurological and neuropsychiatric diseases including rare disorders. The company is rapidly progressing multiple compounds in clinical trials across three platforms they are calcitonin gene related peptide receptor antagonism, glutamate modulation and myeloperoxidase inhibition. The headquarters is in USA.

  8. Zhejiang Jiuzhou Pharmaceutical Co. Ltd

    World Rank (Aug-2026)
    6,008
    Market Cap (Aug-2026)
    2.208 Billion USD
    World Rank (Jan-05-2024)
    4,571
    Market Cap (Jan-05-2024)
    2.829 Billion USD
    World Rank (Jul-30-2023)
    4,094
    Market Cap (Jul-30-2023)
    3.276 Billion USD
    World Rank (Dec-25-2022)
    2,941
    Market Cap (Dec-25-2022)
    4.584 Billion USD
    World Rank (Jan-07-2022)
    2,722
    Market Cap (Jan-07-2022)
    6.31 Billion USD
    Annual Revenue in USD
    591 Million USD
    Annual Net Income in USD
    92 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Zhejiang Jiuzhou Pharmaceutical Co. Ltd is committed to the research and development, production and sale of active pharmaceutical ingredients company. It has undertaken more than 30 national and provincial research projects. The company annual revenue is 306 million USD and 2,998 employees as on 2019. The headquarters is in China.
  9. Hanall Biopharma

    World Rank (Aug-2026)
    6,045
    Market Cap (Aug-2026)
    2.183 Billion USD
    World Rank (Jan-05-2024)
    6,572
    Market Cap (Jan-05-2024)
    1.580 Billion USD
    World Rank (Jul-30-2023)
    9,371
    Market Cap (Jul-30-2023)
    0.883 Billion USD
    World Rank (Dec-25-2022)
    10,789
    Market Cap (Dec-25-2022)
    0.651 Billion USD
    World Rank (Jan-07-2022)
    10,233
    Market Cap (Jan-07-2022)
    0.86 Billion USD
    Annual Revenue in USD
    76 Million USD
    Annual Net Income in USD
    7 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Pharmaceutical Company with headquarters is in Seoul, South Korea.
  10. Granules India

    World Rank (Aug-2026)
    6,057
    Market Cap (Aug-2026)
    2.175 Billion USD
    World Rank (Jan-05-2024)
    7,635
    Market Cap (Jan-05-2024)
    1.222 Billion USD
    World Rank (Jul-30-2023)
    9,022
    Market Cap (Jul-30-2023)
    0.946 Billion USD
    World Rank (Dec-25-2022)
    8,556
    Market Cap (Dec-25-2022)
    0.964 Billion USD
    World Rank (Jan-07-2022)
    9,099
    Market Cap (Jan-07-2022)
    1.06 Billion USD
    Annual Revenue in USD
    467 Million USD
    Annual Net Income in USD
    52 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile
    Granules India is a vertically integrated, high-growth pharmaceutical product manufacturing company. The company annual revenue is 37,649 million INR and annual net income is 4,127 million INR for year ending March 2022. The headquarters is in India.

Share

Ads